恩远医药科技(北京)有限公司

About 恩远医药科技(北京)有限公司

Enyuan Pharmaceutical Technology (Beijing) Co., Ltd. (E&Y) is a holding subsidiary of A+H share listed company KANGLONG Huacheng. Founded in 2015, it is an international contract research organization (CRO) with a professional, efficient, and stable excellent clinical research team and a consulting group of senior domestic and foreign medical R&D experts. We are committed to providing customers with high-quality quantitative pharmacology research and refined clinical development services. Through cooperation with domestic and foreign pharmaceutical enterprises, Enyuan Pharmaceutical has established international standard operating procedures (SOP) that align with China's actual situation. We have built stable and positive cooperative relationships with national clinical research institutions in fields such as cardiovascular, neurological, oncology, pediatrics, respiratory, endocrine, antibiotics, dermatology, and gynecology. The domestic team of Enyuan company is centered in Beijing, with personnel extending to 15 large and medium-sized cities. Our business scope covers China, the United States, and the European Union, and our project products encompass drugs, medical devices, and diagnostic reagents.